PubMed Health⌕ Search

Biomedical subjects

T Shimano

Publications and source records attributed to T Shimano.

At least 91 records · Page 5Linked to original sources
PubMed1987

Usefulness of carcinoembryonic antigen measurement in feces of patients with colorectal cancer.

Anticarcinoembryonic antigen (CEA) antisera which showed no reactions with normal adult feces were prepared in guinea pigs. Using these, levels of CEA in feces from patients with colorectal carcinoma were measured by gel diffusion and rocket immunoelectrophoresis. Sixteen of 22 (73 percent) patients with carcinoma of the colon or rectum (Dukes' A4/6, B6/8, C6/7, D0/1) had detectable CEA in their feces, while none was detected in the feces of four patients with gastric ulcers or in those of 22 normal volunteers. Five of the 16 fecal CEA-positive patients showed no elevation of plasma CEA levels. Measurements using a commercial CEA kit (Abbott Laboratories) could not detect the differences between fecal CEA values of patients with colorectal carcinoma and benign diseases, or those of normal volunteers. These results suggest that measurement of fecal CEA by specific anti-CEA antisera will be valuable in screening and diagnosis of colorectal carcinoma.

Carcinoembryonic Antigen↗
PubMed1987

Use of sulfonated probes for in situ detection of amylase mRNA in formalin-fixed paraffin sections of human pancreas and submaxillary gland.

A sulfonated probe and its applicability to in situ hybridization is described and discussed. The DNA probes were modified by introducing an antigenic sulfone group into the cytidine residues of the denatured DNA (Budowsky EI, Sverdlov ED, Monastyrkaya GS: New method of selective and rapid modification of the cytidine residues. FEBS Lett 25:201, 1972). Hybridization of the sulfonated DNA with the target nucleic acid sequences was confirmed by an avidin-biotin peroxidase complex method using a monoclonal antibody specific to sulfonated DNA. The detection limit of this system was estimated to be about 1.25 pg of actual target sequences by dot blot hybridization analysis. When the sulfonated probes of human amylase cDNA were applied to in situ hybridization immunohistochemistry on formalin-fixed paraffin sections of the human pancreas and submaxillary gland, hybridization signals were clearly localized in the cytoplasm of the acinar cells of the pancreas, and in the serous cells of the submaxillary gland. Suitable probe lengths for in situ hybridization immunohistochemistry were between 100 and 800 bases. The in situ hybridization technique utilizing a sulfonated DNA probe is sensitive, simple, and easy to perform and applicable to studies of cell biology.

Amylases↗
PubMed1986

Pancreas cancer associated antigen from normal colonic mucosa (PCAAc) assayed with monoclonal antibody.

We prepared monoclonal antibodies against pancreatic cancer associated antigen (PCAA) from normal colonic mucosa (PCAAc) and prepared an assay system to detect the circulating PCAAc in sera. 200 patients with cancer including 85 pancreatic cancer and benign disease were compared with 40 normal healthy individuals. Diagnostic rate of pancreatic cancer was 64/85 (75%) but other malignancy also showed elevated PCAAc: 18/19 (94.7%) of hepatoma and 19/37 (51.4%) of gastric cancer. In pancreatitis, 8/17 (47.1%) showed elevated PCAAc. Compared with our previous reports of PCAA assay, these results indicated that diagnostic sensitivity of pancreatic cancer was increased but specificity of it was decreased.

Antibodies, Monoclonal↗
PubMed1986

Activated macrophage hybridomas secreting a cytotoxic factor.

Stable activated macrophage hybridomas were generated by somatic cell fusion between Propionibacterium acnes-induced peritoneal exudate cells and NS-1 myeloma cells. Five cell lines were obtained and each was cloned by limiting dilution; 59 clones were obtained. The cells of 2 clones (MP4-4 and MP4-8) which adhered to the culture dishes were selected for further analysis. These hybridomas exhibited non-specific esterase and beta-galactosidase intracellularly, and asialo GM1, Mac-1, Ia antigens and Fc-receptors on their cell surface. They did not, however, show phagocytic activity or secrete lysozyme. These hybridomas (MP4-4 and MP4-8) secreted the cytotoxic factor without any stimulation. Furthermore strong cytotoxic activity was found in ascites and sera from nude mice inoculated with these hybridomas. These activated macrophage hybridomas should be very useful in studies on cancer immunology and the physiology of macrophages.

Animals↗
PubMed1986

[A case of multiple liver metastases from sigmoid carcinoma treated successfully with arterial infusion chemotherapy].

A 63-year-old female, who had undergone sigmoidectomy for sigmoid carcinoma one year before, was admitted for multiple liver metastases. A urokinase-immobilized catheter was introduced into the proper hepatic artery via the gastroepiploic artery operatively. A daily arterial infusion of 5-FU (250 mg) was combined with a weekly arterial infusion of adriamycin (30 mg) or MMC (10 mg). After discharge, 5-FU (200 mg/day) was given orally and MMC (10 mg) was infused intraarterially every other week at an outpatient clinic. ADR or MMC was infused with angiotensin II, known to increase arterial blood supply to a malignant lesion. Ultrasonography demonstrated 35 to 50% reduction in tumor diameter. The density of metastases seen in computerized tomography became low indicating tumor necrosis. Plasma CEA level, which had initially been as high as 864 ng/ml, decreased rapidly and has remained within normal limits up to the present time. Arterial infusion chemotherapy using 5-FU, ADR or MMC in combination with angiotensin II seems to be effective in the treatment of multiple hepatic metastases from colorectal carcinoma.

Adenocarcinoma↗
PubMed1986

[Diagnosis and treatment of colorectal cancer using monoclonal antibodies].

The clinical usefulness of monoclonal antibodies was discussed from the viewpoint of serodiagnosis, immunohistochemistry, radio immunodetection and therapy. Monoclonal antibodies against carcinoembryonic antigen (CEA) were shown to be more beneficial than polyclonal antibodies. Carbohydrate antigens such as CA 19-9 or CA 50 were also available as tumor markers of colorectal cancer to a certain extent.

Antibodies, Monoclonal↗
PubMed1986

Induction of tumor necrosis factor by administration of OK-432 in cancer patients.

We examined whether OK-432, a streptococcal preparation, could induce tumor necrosis factor in cancer patients. OK-432 was administered at a dose of 100 KE intratumorally to 4 advanced gastric cancer patients and 10KE intracavitary to 8 patients with malignant pleuroperitoneal effusion. The cytostatic activity of the sera and malignant effusions was assayed by the growth inhibition of L929 cells. OK-432 induced significant cytostatic activity in the sera and malignant effusions. The activity was partially neutralized by the monoclonal antibody against human recombinant tumor necrosis factor. These data suggest that OK-432 induces tumor necrosis factor in the sera and malignant effusions of cancer patients.

Biological Products↗
PubMed1984

Purification and characterization of a pancreas cancer-associated antigen from normal colonic mucosa.

Pancreas cancer-associated antigen (PCAAc) was extracted, isolated and purified from human normal colonic mucosa. Purified PCAAc from normal colonic mucosa was homogeneous, as determined by polyacrylamide disc gel electrophoresis. The PCAAc had a molecular weight of approximately 600 000 and consisted of 30% carbohydrate and 70% protein. It had an isoelectric point of 4.4, and migrated to the alpha 2-beta region on immunoelectrophoresis. It was apparently different from other known gastrointestinal mucus antigens. Antiserum against purified PCAAc did not react with normal human serum, pancreas, liver, spleen or lung, but did react with ascites fluid from a patient with pancreatic cancer. PCAAc appears to be a mucus antigen that is associated with pancreatic cancer.

Amino Acids↗
PubMed1984

[The indication and effect of radiation therapy in rectal carcinoma].

A total of sixty one patients with carcinoma of the rectum accepted radiotherapy of 40 Gy/4W to whole pelvis including the perineum. Randomized study of preoperative radiation to the pelvis showed that patients with advanced carcinoma of the lower rectum and the anus benefited in the prevention of the local recurrence and in the curability of unresectable tumor. Postoperative radiation therapy was indicated in the case of the residual tumor, metastatic lymphnodes, distinct lymphatic permeation and insufficient excision of the rectum. For the pelvic recurrence irradiation of doses more than 36 Gy was effective in the case of slow growing tumor. A radical treatment is expected for patients with inoperable tumor or for patients without indication of major surgery because of age or medical problems by the whole pelvic irradiation plus interstitial irradiation.

Adult↗
PubMed1983

Purification and characterization of a pancreatic cancer-associated antigen (PCAA) from normal colonic mucosa.

The same antigenic substance as pancreatic cancer-associated antigen (PCAA), sharing an identical immunogenicity with Gelder's POA, was isolated and purified from normal colonic mucosa. Purified colonic PCAA (PCAAc) is a glycoprotein with a molecular weight of approximately 600,000; it consists of 30% carbohydrates and 70% peptides, and appears to be an N-glycosidic glycoprotein. Antiserum raised against purified PCAAc showed one fused line with our original anti-PCAA antiserum to ascites fluid from patients with pancreatic cancer and extract from normal colonic mucosa. Circulating PCAAc levels assayed by rocket immunoelectrophoresis showed significant elevation in sera of patients with carcinoma of the pancreas. It is concluded that PCAA might be a new tumor-associated antigen which is produced ectopically during oncogenesis.

Amino Acids↗
PubMed1983

Differential distribution of the pancreatic cancer-associated antigen (PCAA) and pancreatic tissue antigen (PaA) in pancreatic and gastrointestinal cancer tissues.

PCAA, a glycoprotein antigen fractionated from the ascites fluid of a patient with pancreatic cancer and sharing an identical immunogenicity with Gelder's POA, and PaA, a novel pancreatic tissue antigen, were studied immunohistologically. Serial paraffin sections were prepared from surgical specimens of 11 cases of pancreatic cancer, 15 of gastric cancer, 12 of colonic cancer, and 2 of gallbladder cancer; these were then subjected to immunofluorescence and immunoperoxidase stainings. In noncancerous tissues, PCAA was detected unexpectedly at goblet cells of the whole intestine, but was completely absent in pancreatic tissues, while PaA was not demonstrated in intestinal tissues, but was positive at acinar cells of the pancreas. In pancreatic cancer tissues, PCAA and PaA were detected at apical cytoplasm of cancer cells, although positive cells were in different proportions and had different distributions. PCAA-positive cells were mucin-producing (positive in PAS-alcian blue staining) and were well differentiated histologically, while PaA-positive cells were less differentiated and poor in mucin production. Among 11 cases of pancreatic cancer, both PCAA- and PaA-positive cells were demonstrated in 3 cases, PCAA-positive cells alone were found in 3 cases, and PaA-positive cells alone were seen in 4 cases. In 27 gastrointestinal cancer tissues, PCAA was detected in 7 cases of mucin-producing cancer, and PaA was demonstrated in 2 cases of poorly differentiated adenocarcinoma.

Adenocarcinoma↗